These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2793275)

  • 1. Theophylline toxicity risks and chronic renal failure.
    Nicot G; Charmes JP; Lachatre G; Sautereau D; Valette JP; Eichler B; Leroux-Robert C
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):398-401. PubMed ID: 2793275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair zinc compared with plasma zinc in uremic patients before and during regular hemodialysis.
    Mountokalakis T; Dakanalis D; Boukis D; Virvidakis K; Voudiklari S; Koutselinis A
    Clin Nephrol; 1979 Nov; 12(5):206-9. PubMed ID: 509794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
    Yu SY; Chung HC; Kim EJ; Kim SH; Lee I; Kim SG; Lee MG
    J Pharm Pharmacol; 2002 Dec; 54(12):1687-92. PubMed ID: 12542900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of high performance liquid chromatography in study of sulphur amino acid metabolism in uremic patients.
    Qureshi GA; Baig SM
    Biochem Mol Biol Int; 1993 Feb; 29(2):359-68. PubMed ID: 8495218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorometric study of serum in patients with chronic renal failure.
    Hadjivassiliou AG; Digenis GE; Mayopoulou-Symvoulidis D; Voudiclari S; Tsaparas N; Symvoulidis A
    Clin Nephrol; 1984 Jul; 22(1):39-43. PubMed ID: 6478660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
    Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
    Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
    J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of cefotaxime and metabolites in uremic patients (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Godin M; Humbert G
    Nephrologie; 1982; 3(1):12-8. PubMed ID: 6283411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis.
    Cano AE; Neil AK; Kang JY; Barnabas A; Eastwood JB; Nelson SR; Hartley I; Maxwell D
    Am J Gastroenterol; 2007 Sep; 102(9):1990-7. PubMed ID: 17511755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of oxidative stress in patients with chronic renal failure].
    González Rico M; Puchades MJ; García Ramón R; Saez G; Tormos MC; Miguel A
    Nefrologia; 2006; 26(2):218-25. PubMed ID: 16808260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.